Yutong Wu, Shen Sun, Chen Zhang, Xiangge Ma, Xinyu Zhu, Yanxue Li, Lan Lin, Zhenrong Fu
{"title":"区域脑老化差异指数:神经退行性疾病和慢性疾病特异性的区域脑老化状态指数。","authors":"Yutong Wu, Shen Sun, Chen Zhang, Xiangge Ma, Xinyu Zhu, Yanxue Li, Lan Lin, Zhenrong Fu","doi":"10.3390/bioengineering12060607","DOIUrl":null,"url":null,"abstract":"<p><p>This study proposes a novel brain-region-level aging assessment paradigm based on Shapley value interpretation, aiming to overcome the interpretability limitations of traditional brain age prediction models. Although deep-learning-based brain age prediction models using neuroimaging data have become crucial tools for evaluating abnormal brain aging, their unidimensional brain age-chronological age discrepancy metric fails to characterize the regional heterogeneity of brain aging. Meanwhile, despite Shapley additive explanations having demonstrated potential for revealing regional heterogeneity, their application in complex deep learning algorithms has been hindered by prohibitive computational complexity. To address this, we innovatively developed a computational framework featuring efficient Shapley value approximation through a novel multi-stage computational strategy that significantly reduces complexity, thereby enabling an interpretable analysis of deep learning models. By establishing a reference system based on standard Shapley values from healthy populations, we constructed an anatomically specific Regional Brain Aging Deviation Index (RBADI) that maintains age-related validity. Experimental validation using UK Biobank data demonstrated that our framework successfully identified the thalamus (THA) and hippocampus (HIP) as core contributors to brain age prediction model decisions, highlighting their close associations with physiological aging. Notably, it revealed significant correlations between the insula (INS) and alcohol consumption, as well as between the inferior frontal gyrus opercular part (IFGoperc) and smoking history. Crucially, the RBADI exhibited superior performance in the tri-class classification of prodromal neurodegenerative diseases (HCs vs. MCI vs. AD: AUC = 0.92; HCs vs. pPD vs. PD: AUC = 0.86). This framework not only enables the practical implementation of Shapley additive explanations in brain age prediction deep learning models but also establishes anatomically interpretable biomarkers. These advancements provide a novel spatial analytical dimension for investigating brain aging mechanisms and demonstrate significant clinical translational value for early neurodegenerative disease screening, ultimately offering a new methodological tool for deciphering the neural mechanisms of aging.</p>","PeriodicalId":8874,"journal":{"name":"Bioengineering","volume":"12 6","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2025-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12189761/pdf/","citationCount":"0","resultStr":"{\"title\":\"Regional Brain Aging Disparity Index: Region-Specific Brain Aging State Index for Neurodegenerative Diseases and Chronic Disease Specificity.\",\"authors\":\"Yutong Wu, Shen Sun, Chen Zhang, Xiangge Ma, Xinyu Zhu, Yanxue Li, Lan Lin, Zhenrong Fu\",\"doi\":\"10.3390/bioengineering12060607\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>This study proposes a novel brain-region-level aging assessment paradigm based on Shapley value interpretation, aiming to overcome the interpretability limitations of traditional brain age prediction models. Although deep-learning-based brain age prediction models using neuroimaging data have become crucial tools for evaluating abnormal brain aging, their unidimensional brain age-chronological age discrepancy metric fails to characterize the regional heterogeneity of brain aging. Meanwhile, despite Shapley additive explanations having demonstrated potential for revealing regional heterogeneity, their application in complex deep learning algorithms has been hindered by prohibitive computational complexity. To address this, we innovatively developed a computational framework featuring efficient Shapley value approximation through a novel multi-stage computational strategy that significantly reduces complexity, thereby enabling an interpretable analysis of deep learning models. By establishing a reference system based on standard Shapley values from healthy populations, we constructed an anatomically specific Regional Brain Aging Deviation Index (RBADI) that maintains age-related validity. Experimental validation using UK Biobank data demonstrated that our framework successfully identified the thalamus (THA) and hippocampus (HIP) as core contributors to brain age prediction model decisions, highlighting their close associations with physiological aging. Notably, it revealed significant correlations between the insula (INS) and alcohol consumption, as well as between the inferior frontal gyrus opercular part (IFGoperc) and smoking history. Crucially, the RBADI exhibited superior performance in the tri-class classification of prodromal neurodegenerative diseases (HCs vs. MCI vs. AD: AUC = 0.92; HCs vs. pPD vs. PD: AUC = 0.86). This framework not only enables the practical implementation of Shapley additive explanations in brain age prediction deep learning models but also establishes anatomically interpretable biomarkers. These advancements provide a novel spatial analytical dimension for investigating brain aging mechanisms and demonstrate significant clinical translational value for early neurodegenerative disease screening, ultimately offering a new methodological tool for deciphering the neural mechanisms of aging.</p>\",\"PeriodicalId\":8874,\"journal\":{\"name\":\"Bioengineering\",\"volume\":\"12 6\",\"pages\":\"\"},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2025-06-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12189761/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bioengineering\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://doi.org/10.3390/bioengineering12060607\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ENGINEERING, BIOMEDICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioengineering","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3390/bioengineering12060607","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
摘要
为了克服传统脑年龄预测模型的可解释性局限性,提出了一种基于Shapley值解释的脑区域级衰老评估范式。尽管使用神经成像数据的基于深度学习的脑年龄预测模型已成为评估异常脑衰老的重要工具,但其一维脑年龄-实足年龄差异度量未能表征脑衰老的区域异质性。与此同时,尽管Shapley加性解释已经证明了揭示区域异质性的潜力,但它们在复杂深度学习算法中的应用受到了令人望而却步的计算复杂性的阻碍。为了解决这个问题,我们创新地开发了一个计算框架,通过一种新的多阶段计算策略,显著降低了复杂性,从而实现了深度学习模型的可解释分析。通过建立一个基于健康人群标准Shapley值的参考系统,我们构建了一个解剖学特异性的区域脑老化偏差指数(RBADI),该指数保持了与年龄相关的有效性。使用UK Biobank数据的实验验证表明,我们的框架成功地确定了丘脑(THA)和海马体(HIP)是大脑年龄预测模型决策的核心贡献者,突出了它们与生理衰老的密切联系。值得注意的是,它揭示了脑岛(INS)与饮酒之间以及额下回(IFGoperc)与吸烟史之间的显著相关性。至关重要的是,RBADI在前驱性神经退行性疾病的三类分类中表现出优越的表现(hcc vs. MCI vs. AD: AUC = 0.92;hcc vs. pPD vs. PD: AUC = 0.86)。该框架不仅使Shapley加性解释在脑年龄预测深度学习模型中的实际实施成为可能,而且还建立了解剖学上可解释的生物标志物。这些进展为研究大脑衰老机制提供了一个新的空间分析维度,并为早期神经退行性疾病筛查展示了重要的临床转化价值,最终为破译衰老的神经机制提供了一种新的方法工具。
Regional Brain Aging Disparity Index: Region-Specific Brain Aging State Index for Neurodegenerative Diseases and Chronic Disease Specificity.
This study proposes a novel brain-region-level aging assessment paradigm based on Shapley value interpretation, aiming to overcome the interpretability limitations of traditional brain age prediction models. Although deep-learning-based brain age prediction models using neuroimaging data have become crucial tools for evaluating abnormal brain aging, their unidimensional brain age-chronological age discrepancy metric fails to characterize the regional heterogeneity of brain aging. Meanwhile, despite Shapley additive explanations having demonstrated potential for revealing regional heterogeneity, their application in complex deep learning algorithms has been hindered by prohibitive computational complexity. To address this, we innovatively developed a computational framework featuring efficient Shapley value approximation through a novel multi-stage computational strategy that significantly reduces complexity, thereby enabling an interpretable analysis of deep learning models. By establishing a reference system based on standard Shapley values from healthy populations, we constructed an anatomically specific Regional Brain Aging Deviation Index (RBADI) that maintains age-related validity. Experimental validation using UK Biobank data demonstrated that our framework successfully identified the thalamus (THA) and hippocampus (HIP) as core contributors to brain age prediction model decisions, highlighting their close associations with physiological aging. Notably, it revealed significant correlations between the insula (INS) and alcohol consumption, as well as between the inferior frontal gyrus opercular part (IFGoperc) and smoking history. Crucially, the RBADI exhibited superior performance in the tri-class classification of prodromal neurodegenerative diseases (HCs vs. MCI vs. AD: AUC = 0.92; HCs vs. pPD vs. PD: AUC = 0.86). This framework not only enables the practical implementation of Shapley additive explanations in brain age prediction deep learning models but also establishes anatomically interpretable biomarkers. These advancements provide a novel spatial analytical dimension for investigating brain aging mechanisms and demonstrate significant clinical translational value for early neurodegenerative disease screening, ultimately offering a new methodological tool for deciphering the neural mechanisms of aging.
期刊介绍:
Aims
Bioengineering (ISSN 2306-5354) provides an advanced forum for the science and technology of bioengineering. It publishes original research papers, comprehensive reviews, communications and case reports. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. All aspects of bioengineering are welcomed from theoretical concepts to education and applications. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced. There are, in addition, four key features of this Journal:
● We are introducing a new concept in scientific and technical publications “The Translational Case Report in Bioengineering”. It is a descriptive explanatory analysis of a transformative or translational event. Understanding that the goal of bioengineering scholarship is to advance towards a transformative or clinical solution to an identified transformative/clinical need, the translational case report is used to explore causation in order to find underlying principles that may guide other similar transformative/translational undertakings.
● Manuscripts regarding research proposals and research ideas will be particularly welcomed.
● Electronic files and software regarding the full details of the calculation and experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material.
● We also accept manuscripts communicating to a broader audience with regard to research projects financed with public funds.
Scope
● Bionics and biological cybernetics: implantology; bio–abio interfaces
● Bioelectronics: wearable electronics; implantable electronics; “more than Moore” electronics; bioelectronics devices
● Bioprocess and biosystems engineering and applications: bioprocess design; biocatalysis; bioseparation and bioreactors; bioinformatics; bioenergy; etc.
● Biomolecular, cellular and tissue engineering and applications: tissue engineering; chromosome engineering; embryo engineering; cellular, molecular and synthetic biology; metabolic engineering; bio-nanotechnology; micro/nano technologies; genetic engineering; transgenic technology
● Biomedical engineering and applications: biomechatronics; biomedical electronics; biomechanics; biomaterials; biomimetics; biomedical diagnostics; biomedical therapy; biomedical devices; sensors and circuits; biomedical imaging and medical information systems; implants and regenerative medicine; neurotechnology; clinical engineering; rehabilitation engineering
● Biochemical engineering and applications: metabolic pathway engineering; modeling and simulation
● Translational bioengineering